FDA exempts naloxone distribution from DSCSA tracking requirements

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Combination ProductsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySupply Chain Management